MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma-Reference-Cited by-同舟云学术

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma

Published:2016-10-25 Issue:48 Volume:7 Page:79584-79595
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tian Tian¹²,Mingyi Ma¹,Qiu Xia³,Qiu Yang⁴

Affiliation:

1. Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People's Republic of China

2. Department of Neurology, Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People's Republic of China

3. Department of Medicine, Shangqiu Medical School, Shangqiu 476000, Henan Province, People's Republic of China

4. Department of Clinical Medicine, Shaoyang Medical College, Shaoyang 422000, Hunan Province, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide;Molecular Neurobiology;2024-07-18

2. MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma;Molecular Brain;2024-07-02

3. Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma;International Journal of Molecular Sciences;2024-02-20

4. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review;International Journal of Biological Macromolecules;2024-02

5. Autophagy Intervened by MicroRNAs Causes Gliomas;Journal of Neuro and Oncology Research;2023-11-16